Genocea Biosciences Inc Share Price Nasdaq
Equities
US3724271040
Biotechnology & Medical Research
Sales 2020 | 1.36M 107M | Sales 2021 | 1.64M 130M | Capitalization | 66.64M 5.27B |
---|---|---|---|---|---|
Net income 2020 | -43M -3.4B | Net income 2021 | -33M -2.61B | EV / Sales 2020 | 50.8 x |
Net cash position 2020 | 55.9M 4.42B | Net cash position 2021 | 19.96M 1.58B | EV / Sales 2021 | 28.4 x |
P/E ratio 2020 |
-2.18
x | P/E ratio 2021 |
-2.4
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 52 | 28/02/07 | |
Girish Aakalu
PRN | Corporate Officer/Principal | - | 09/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 10/09/14 |
1st Jan change | Capi. | |
---|---|---|
+19.41% | 45.51B | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |